Cardiovascular protection with antihypertensive drugs in dialysis patients systematic review and meta-analysis

Research output: Contribution to journalArticle

136 Scopus citations


Epidemiological studies demonstrate that a lower blood pressure and decline in blood pressure over months or years are associated with higher mortality in dialysis patients. In contrast, randomized, controlled trials lack power to establish benefits of antihypertensive therapy. Patients on long-term dialysis participating in randomized, controlled trials and receiving antihypertensive drug therapy were the subject of this meta-analysis. Outcomes assessed were the hazard ratio of cardiovascular events and all-cause mortality in treated group compared with controls. Among 1202 patients who we identified in 5 studies, the overall benefit of antihypertensive therapy compared with the control or placebo group had a combined hazard ratio for cardiovascular events of 0.69 (95% CI: 0.56 to 0.84) using a fixed-effects model and 0.62 (95% CI: 0.45 to 0.86) using a random-effects model. In a sensitivity analysis, we found that the hypertensive group had a pooled hazard ratio of 0.49 (95% CI: 0.35 to 0.67), but when normotensives were included in the trial, lesser cardiovascular protection was seen (pooled hazard ratio of 0.86 [95% CI: 0.67 to 1.12]). Test for heterogeneity between hypertensive and "normotensive-included" groups was significant (P<0.006). Similar results were seen for risk ratio for death and cardiovascular events. There was evidence of publication bias based on Egger's test and funnel plot. Randomized trials suggested a benefit of antihypertensive therapy among hemodialysis patients. Adequately powered randomized trials are required to confirm these observations, especially among those with hypertension.

Original languageEnglish (US)
Pages (from-to)860-866
Number of pages7
Issue number5
StatePublished - May 1 2009


  • Cardiovascular events
  • Hemodialysis
  • Hypertension
  • Reverse epidemiology
  • Systematic review
  • Treatment

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Cardiovascular protection with antihypertensive drugs in dialysis patients systematic review and meta-analysis'. Together they form a unique fingerprint.

  • Cite this